TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)
Clinical trial NCT02117427 · COMPLETED
Trial details
- NCT number
- NCT02117427
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-27
- Primary completion
- 2016-06-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.